GW Henssler & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Buy
2,465
+43
+2% +$10K 0.03% 131
2026
Q1
$592K Buy
2,422
+79
+3% +$18.4K 0.03% 134
2025
Q4
$485K Sell
2,343
-23
-1% -$4.55K 0.02% 134
2025
Q3
$439K Sell
2,366
-1,441
-38% -$247K 0.02% 140
2025
Q2
$582K Buy
3,807
+150
+4% +$23.1K 0.03% 121
2025
Q1
$606K Buy
3,657
+1,058
+41% +$166K 0.03% 113
2024
Q4
$421K Hold
2,599
0.02% 117
2024
Q3
$421K Buy
2,599
+55
+2% +$8.76K 0.02% 117
2024
Q2
$372K Buy
2,544
+66
+3% +$9.82K 0.02% 109
2024
Q1
$392K Buy
2,478
+102
+4% +$16.2K 0.02% 109
2023
Q4
$372K Buy
2,376
+108
+5% +$16.6K 0.02% 107
2023
Q3
$353K Sell
2,268
-76
-3% -$12.5K 0.02% 117
2023
Q2
$388K Sell
2,344
-145
-6% -$23.4K 0.03% 118
2023
Q1
$386K Buy
2,489
+192
+8% +$31K 0.03% 132
2022
Q4
$406K Buy
2,297
+122
+6% +$21.1K 0.03% 120
2022
Q3
$355K Sell
2,175
-932
-30% -$158K 0.03% 120
2022
Q2
$552K Hold
3,107
0.04% 98
2022
Q1
$551K Sell
3,107
-606
-16% -$103K 0.03% 110
2021
Q4
$635K Buy
+3,713
New +$608K 0.04% 114
2021
Q3
Sell
-3,319
Closed -$547K 169
2021
Q2
$547K Sell
3,319
-1,000
-23% -$166K 0.04% 118
2021
Q1
$710K Buy
4,319
+76
+2% +$12.3K 0.05% 101
2020
Q4
$668K Buy
4,243
+188
+5% +$27.7K 0.05% 99
2020
Q3
$604K Buy
4,055
+251
+7% +$37.1K 0.05% 93
2020
Q2
$535K Sell
3,804
-107
-3% -$15.6K 0.05% 96
2020
Q1
$513K Buy
3,911
+976
+33% +$138K 0.05% 95
2019
Q4
$428K Buy
2,935
+94
+3% +$12.8K 0.04% 154
2019
Q3
$368K Buy
2,841
+88
+3% +$11.6K 0.03% 136
2019
Q2
$383K Sell
2,753
-341
-11% -$47.2K 0.03% 153
2019
Q1
$433K Sell
3,094
-120,054
-97% -$16.1M 0.04% 144
2018
Q4
$15.9M Sell
123,148
-4,948
-4% -$690K 1.7% 17
2018
Q3
$17.7M Buy
128,096
+8,639
+7% +$1.15M 1.61% 14
2018
Q2
$14.5M Buy
119,457
+1,276
+1% +$159K 1.42% 23
2018
Q1
$15.1M Sell
118,181
-1,815
-2% -$245K 1.52% 14
2017
Q4
$16.8M Buy
119,996
+795
+0.7% +$111K 1.57% 14
2017
Q3
$15.5M Sell
119,201
-1,128
-0.9% -$150K 1.55% 13
2017
Q2
$15.9M Buy
120,329
+579
+0.5% +$73.9K 1.66% 11
2017
Q1
$14.9M Buy
119,750
+587
+0.5% +$70.1K 1.61% 12
2016
Q4
$13.7M Sell
119,163
-3,296
-3% -$381K 1.52% 17
2016
Q3
$14.5M Buy
122,459
+981
+0.8% +$119K 1.65% 15
2016
Q2
$14.7M Buy
121,478
+3,543
+3% +$403K 1.7% 15
2016
Q1
$12.8M Buy
117,935
+937
+0.8% +$97K 1.5% 18
2015
Q4
$12M Sell
116,998
-126
-0.1% -$12.7K 1.42% 19
2015
Q3
$10.9M Buy
117,124
+3,586
+3% +$347K 1.25% 19
2015
Q2
$11.1M Buy
113,538
+73,009
+180% +$7.31M 1.2% 24
2015
Q1
$4.08M Buy
40,529
+30,244
+294% +$3.08M 0.47% 55
2014
Q4
$1.08M Buy
10,285
+514
+5% +$54.2K 0.12% 101
2014
Q3
$1.04M Sell
9,771
-112
-1% -$11.6K 0.13% 96
2014
Q2
$1.03M Sell
9,883
-8,475
-46% -$857K 0.13% 94
2014
Q1
$1.8M Sell
18,358
-673
-4% -$62.4K 0.21% 86
2013
Q4
$1.74M Sell
19,031
-357
-2% -$32.9K 0.2% 85
2013
Q3
$1.68M Sell
19,388
-48
-0.2% -$4.31K 0.22% 83
2013
Q2
$1.67M Buy
+19,436
New +$1.65M 0.23% 79

Other funds holding JNJ

GW Henssler & Associates's JNJ Position: Q2 2026 in Review

GW Henssler & Associates increased its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2026, buying an estimated $10K and bringing the position to 2,465 shares worth $626K. The position accounts for 0.03% of the portfolio, ranked #131.

GW Henssler & Associates first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.7M in Q3 2018. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • GW Henssler & Associates held 2,465 shares of Johnson & Johnson worth $626K as of Q2 2026.
  • GW Henssler & Associates bought 43 Johnson & Johnson shares in Q2 2026, an estimated $10K.
  • Johnson & Johnson made up 0.03% of GW Henssler & Associates's portfolio in Q2 2026, its #131 holding.
  • GW Henssler & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • GW Henssler & Associates's Johnson & Johnson position peaked at $17.7M in Q3 2018.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.